# Unraveling the genetic links between stature and disease in East Asians: A multi-biobank genetic correlation and risk prediction study

**Authors:** Ying-Ju Lin, Ting-Yuan Liu, Jai-Sing Yang, Ju-Pi Li, Jian-Shiun Chiou, Hsing-Fang Lu, Kuyuri Ariyoshi, Keiko Hikino, Chikashi Terao, Chen-Hsing Chou, Wen-Miin Liang, I-Ching Chou, Ting-Hsu Lin, Chiu-Chu Liao, Shao-Mei Huang, Fuu-Jen Tsai, Anne O'Donnell-Luria, Anne O'Donnell-Luria, Anne O'Donnell-Luria, Anne O'Donnell-Luria

PMC · DOI: 10.1371/journal.pgen.1012030 · PLOS Genetics · 2026-03-13

## TL;DR

This study explores how genes related to height and short stature in East Asians are linked to health risks like heart and reproductive issues, offering insights for precision health strategies.

## Contribution

The study identifies novel genetic links between stature and health outcomes in East Asians using large-scale GWAS and PRS analyses.

## Key findings

- 293 loci for height and 5 for FSS were identified in Han Taiwanese individuals.
- Tall stature is genetically linked to increased risks of atrial fibrillation and endometriosis.
- Short stature shows a weak protective effect against endometriosis.

## Abstract

Both genetic and environmental factors affect human stature, including overall height and familial short stature (FSS), and it is associated with various health outcomes. However, the study of genetic connections between stature and health conditions remains lacking in East Asian populations. Hence, we conducted parallel genome-wide association studies (GWAS) of body height and FSS in the Han Taiwanese population, aiming to elucidate the genetic influences of stature on health and facilitate the formulation of precision-health strategies. We analyzed large-scale GWAS data on adult height (120,301 Han Taiwanese) and FSS (FSS; 2,050 cases, 27,966 controls) to examine cross-trait genetic correlations across five East Asian biobanks, and applied phenome-wide association studies (PheWAS) and polygenic risk score (PRS) analyses to assess clinical outcomes using Cox proportional hazard models and Kaplan–Meier analyses. We identified 293 loci for height and five for FSS, with cross-biobank genetic correlations linking stature to body size, lung function, and cardiovascular/reproductive traits (atrial flutter/fibrillation [AF], menarche, and endometriosis). PheWAS showed that height PRS increased risks of AF and endometriosis, while FSS PRS had a protective effect against endometriosis. MR analyses showed that taller stature increased AF risk independently and endometriosis risk through menarche/weight, while shorter stature had a weak protective effect against endometriosis. Survival analyses showed the association of higher height PRS with greater AF risk and an earlier divergence of cumulative incidence curves. These time-to-event patterns were consistently replicated using meta-analysis–derived PRSs. The findings highlight stature-related genetic determinants, associated health outcomes, and polygenic risk scores as effective tools for early risk prediction and precision health strategies in East Asian populations.

Adult stature, including height and familial short stature (FSS), is influenced by genetic and environmental factors. Although stature has been associated with various health conditions, the genetic basis of stature-related health risks remains underexplored, especially in East Asian populations. Herein, genome-wide association studies (GWAS) of >120,000 Han Taiwanese individuals were analyzed, and 293 loci for height and 5 for FSS were identified. Cross-trait genetic correlations were assessed across five East Asian biobanks and analyzed via phenome-wide association studies and polygenic risk score (PRS) to evaluate clinical implications. Stature traits showed strong genetic correlations with body size, lung function, and cardiovascular and reproductive conditions, particularly AF, menarche timing, and endometriosis. Tall stature was associated with increased risks of AF and endometriosis, whereas short stature conferred a weak protective effect against endometriosis. These associations, confirmed through PRS-based risk estimates and divergence in survival curves, support the use of stature-related genetics for improved disease risk stratification. Our findings indicate that stature is a genetically informed, non-modifiable risk factor with potential utility in early risk prediction and precision health for East Asian populations.

## Linked entities

- **Diseases:** atrial fibrillation (MONDO:0004981), endometriosis (MONDO:0005133)
- **Species:** Homo sapiens (taxon 9606)

## Full-text entities

- **Genes:** THBS2 (thrombospondin 2) [NCBI Gene 7058] {aka EDSCLL3, TSP2}, NSD2 (nuclear receptor binding SET domain protein 2) [NCBI Gene 7468] {aka KMT3F, KMT3G, MMSET, RAUST, REIIBP, TRX5}, DIS3L2 (DIS3 like 3'-5' exoribonuclease 2) [NCBI Gene 129563] {aka FAM6A, PRLMNS, hDIS3L2}, NCAPG (non-SMC condensin I complex subunit G) [NCBI Gene 64151] {aka CAPG, CHCG, NY-MEL-3, YCG1}, ST3GAL4 (ST3 beta-galactoside alpha-2,3-sialyltransferase 4) [NCBI Gene 6484] {aka CGS23, NANTA3, SAT3, SIAT4, SIAT4C, ST-4}, IGF1R (insulin like growth factor 1 receptor) [NCBI Gene 3480] {aka CD221, IGFIR, IGFR, JTK13}, ADAMTS17 (ADAM metallopeptidase with thrombospondin type 1 motif 17) [NCBI Gene 170691] {aka WMS4}, GIGYF2 (GRB10 interacting GYF protein 2) [NCBI Gene 26058] {aka GYF2, PARK11, PERQ2, PERQ3, TNRC15}, ST3 (suppression of tumorigenicity 3) [NCBI Gene 6762] {aka CCTS, TSHL}, DCAF16 (DDB1 and CUL4 associated factor 16) [NCBI Gene 54876] {aka C4orf30}, PIEZO1 (piezo type mechanosensitive ion channel component 1 (Er blood group)) [NCBI Gene 9780] {aka DHS, ER, FAM38A, LMPH3, LMPHM6, Mib}, IGF1 (insulin like growth factor 1) [NCBI Gene 3479] {aka IGF, IGF-I, IGFI, MGF}, WASHC3 (WASH complex subunit 3) [NCBI Gene 51019] {aka CCDC53, CGI-116}, FAM184B (family with sequence similarity 184 member B) [NCBI Gene 27146], CNPY2 (canopy FGF signaling regulator 2) [NCBI Gene 10330] {aka HP10390, MSAP, TMEM4, ZSIG9}, GH1 (growth hormone 1) [NCBI Gene 2688] {aka GH, GH-N, GHB5, GHN, IGHD1A, IGHD1B}, RAD51B (RAD51 paralog B) [NCBI Gene 5890] {aka R51H2, RAD51L1, REC2}, SPRY2 (sprouty RTK signaling antagonist 2) [NCBI Gene 10253] {aka IGAN3, hSPRY2}, EXTL3 (exostosin like glycosyltransferase 3) [NCBI Gene 2137] {aka BOTV, EXTL1L, EXTR1, ISDNA, REGR, RPR}, LTBP3 (latent transforming growth factor beta binding protein 3) [NCBI Gene 4054] {aka DASS, GPHYSD3, LTBP-3, LTBP2, STHAG6, pp6425}, CKB (creatine kinase B) [NCBI Gene 1152] {aka B-CK, BCK, CKBB, CPK-B, HEL-211, HEL-S-29}, ATF7 (activating transcription factor 7) [NCBI Gene 11016] {aka ATFA}, LEP (leptin) [NCBI Gene 3952] {aka LEPD, OB, OBS}, IL23A (interleukin 23 subunit alpha) [NCBI Gene 51561] {aka IL-23, IL-23A, IL23P19, P19, SGRF}, FBP1 (fructose-bisphosphatase 1) [NCBI Gene 2203] {aka FBP}, PAN2 (poly(A) specific ribonuclease subunit PAN2) [NCBI Gene 9924] {aka DEDCRF, USP52}, FNDC3B (fibronectin type III domain containing 3B) [NCBI Gene 64778] {aka FAD104, PRO4979, YVTM2421}, LCORL (ligand dependent nuclear receptor corepressor like) [NCBI Gene 254251] {aka MLR1}, SLC12A6 (solute carrier family 12 member 6) [NCBI Gene 9990] {aka ACCPN, CMT2II, KCC3, KCC3A, KCC3B}, SNX21 (sorting nexin family member 21) [NCBI Gene 90203] {aka C20orf161, PP3993, SNX-L, SNXL, dJ337O18.4}, ZFAT (zinc finger and AT-hook domain containing) [NCBI Gene 57623] {aka AITD3, ZFAT1, ZNF406}, DLEU1 (deleted in lymphocytic leukemia 1) [NCBI Gene 10301] {aka BCMS, BCMS1, DLB1, LEU1, LINC00021, NCRNA00021}, BMP1 (bone morphogenetic protein 1) [NCBI Gene 649] {aka OI13, PCOLC, PCP, TLD}, CS (citrate synthase) [NCBI Gene 1431], MAP3K13 (mitogen-activated protein kinase kinase kinase 13) [NCBI Gene 9175] {aka LZK, MEKK13, MLK}
- **Diseases:** kidney, colorectal, biliary tract, breast, and ovarian cancers (MESH:D010051), Familial (genetic) short stature (MESH:D030342), FSS (MESH:D006130), inflammation (MESH:D007249), hypertension (MESH:D006973), dysmorphisms (MESH:D057215), coronary heart disease (MESH:D003327), cancer (MESH:D009369), hyperlipidemia (MESH:D006949), AF (MESH:D001281), metabolic disorders (MESH:D008659), thyroid dysfunction (MESH:D013959), atopic (MESH:C566404), cardiovascular disease (MESH:D002318), reduced kidney function (MESH:D007680), diminished lung function (MESH:D055370), atrial flutter/fibrillation (MESH:D001282), endometriosis (MESH:D004715), contact dermatitis (MESH:D003877), obesity (MESH:D009765), type 2 diabetes (MESH:D003924), abnormal puberty (MESH:D011628), developmental delays (MESH:D002658)
- **Chemicals:** CREATININE (MESH:D003404), alcohol (MESH:D000438), heparan sulfate (MESH:D006497), ATC_C10AA (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Mutations:** S13C, S13A, S12C, S12A

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13001983/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13001983/full.md

## References

59 references — full list in the complete paper: https://tomesphere.com/paper/PMC13001983/full.md

---
Source: https://tomesphere.com/paper/PMC13001983